Literature DB >> 4580994

Quantitative determination of carbamazepine in plasma by mass fragmentography.

L Palmér, L Bertilsson, P Collste, M Rawlins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4580994     DOI: 10.1002/cpt1973145827

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Disposition of placentally transferred carbamazepine (Tegretol) in the newborn.

Authors:  A Rane; L Bertilsson; L Palmér
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

3.  Distribution and elimination kinetics of carbamazepine in man.

Authors:  M D Rawlins; P Collste; L Bertilsson; L Palmér
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

4.  Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.

Authors:  M Eichelbaum; K Ekbom; L Bertilsson; V A Ringberger; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

5.  Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.

Authors:  M Eichelbaum; T Tomson; G Tybring; L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

6.  Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.

Authors:  M Eichelbaum; L Bertilsson; L Lund; L Palmér; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 7.  Plasma level monitoring of anticonvulsants.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

9.  Use of stable labelled carbamazepine to study its kinetics during chronic carbamazepine treatment.

Authors:  M Eichelbaum; K W Köthe; F Hoffmann; G E von Unruh
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.